BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33332330)

  • 21. Aminobisphosphonate-associated orbital and ocular inflammatory disease.
    Keren S; Leibovitch I; Ben Cnaan R; Neudorfer M; Fogel O; Greenman Y; Shulman S; Zur D; Habot-Wilner Z
    Acta Ophthalmol; 2019 Aug; 97(5):e792-e799. PubMed ID: 30816018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pamidronate disodium and possible ocular adverse drug reactions.
    Macarol V; Fraunfelder FT
    Am J Ophthalmol; 1994 Aug; 118(2):220-4. PubMed ID: 8053468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bilateral Acute Anterior Uveitis and Conjunctivitis following Intravenous Zoledronic Acid.
    Chatterjee S; Agrawal D
    J Assoc Physicians India; 2017 Jul; 65(7):110-111. PubMed ID: 28792180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonate-associated orbital inflammatory disease and uveitis anterior--a case report and review.
    Böni C; Kordic H; Chaloupka K
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):367-9. PubMed ID: 23629782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serious ocular complications of zoledronate.
    Woo TC; Joseph DJ; Wilkinson R
    Clin Oncol (R Coll Radiol); 2006 Sep; 18(7):545-6. PubMed ID: 16969985
    [No Abstract]   [Full Text] [Related]  

  • 26. A case report: zoledronic acid-induced anterior uveitis.
    Kilickap S; Ozdamar Y; Altundag MK; Dizdar O
    Med Oncol; 2008; 25(2):238-40. PubMed ID: 18488162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute Pancreatitis From Treatment With BRAF Inhibitors in Erdheim-Chester Disease: A Report From 2 Tertiary Referral Centers.
    Ruan GJ; Goyal G; Shah MV; Cohen-Aubart F; Amoura Z; Straetmans N; Benameur N; Haroche J; Go RS;
    Pancreas; 2021 Jan; 50(1):e6-e8. PubMed ID: 33370037
    [No Abstract]   [Full Text] [Related]  

  • 28. Drugs, Inflammation, and the Eye.
    Cunningham ET; London NJ; Moorthy R; Garg SJ; Zierhut M
    Ocul Immunol Inflamm; 2016; 24(2):125-7. PubMed ID: 27074544
    [No Abstract]   [Full Text] [Related]  

  • 29. Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study.
    Etminan M; Forooghian F; Maberley D
    CMAJ; 2012 May; 184(8):E431-4. PubMed ID: 22470169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Brimonidine and acute anterior granulomatous uveitis: A case report and literature review].
    Comet A; Donnadieu B; Courjaret JC; Gascon P; Denis D; Matonti F
    J Fr Ophtalmol; 2017 Apr; 40(4):e127-e129. PubMed ID: 28336279
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug-induced uveitis.
    Moorthy RS; Moorthy MS; Cunningham ET
    Curr Opin Ophthalmol; 2018 Nov; 29(6):588-603. PubMed ID: 30222658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced ocular inflammatory diseases.
    Fraunfelder FW
    Drugs Today (Barc); 2007 Feb; 43(2):117-23. PubMed ID: 17353948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anterior uveitis as a side effect of topical brimonidine.
    Byles DB; Frith P; Salmon JF
    Am J Ophthalmol; 2000 Sep; 130(3):287-91. PubMed ID: 11020406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TNF inhibition for ophthalmic indications: current status and outlook.
    Rifkin LM; Birnbaum AD; Goldstein DA
    BioDrugs; 2013 Aug; 27(4):347-57. PubMed ID: 23568177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulatory therapy with tumour necrosis factor α inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results.
    Doycheva D; Zierhut M; Blumenstock G; Stuebiger N; Januschowski K; Voykov B; Deuter C
    Br J Ophthalmol; 2014 Apr; 98(4):523-8. PubMed ID: 24457365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etanercept-associated episcleritis: a pediatric case report of a paradoxical adverse reaction and review of the literature.
    Küçükali B; Gezgin Yıldırım D; Esmeray Şenol P; Özdemir HB; Bakkaloğlu SA
    Clin Rheumatol; 2024 Feb; 43(2):799-808. PubMed ID: 37845415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two case reports of zoledronic acid-induced uveitis.
    Kennedy T; Sellar PW; Vaideanu-Collins D; Ng J
    Age Ageing; 2018 Sep; 47(5):754-755. PubMed ID: 29718071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer.
    El Saghir NS; Otrock ZK; Bleik JH
    BMC Cancer; 2005 Dec; 5():156. PubMed ID: 16332258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series.
    Naqash AR; File DM; Ziemer CM; Whang YE; Landman P; Googe PB; Collichio FA
    J Immunother Cancer; 2019 Jan; 7(1):4. PubMed ID: 30621779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anterior uveitis and topical brimonidine: a case report].
    Velasque L; Ducousso F; Pernod L; Vignal R; Deral V
    J Fr Ophtalmol; 2004 Dec; 27(10):1150-2. PubMed ID: 15687926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.